InterCure Ltd.
INCR
$1.35
-$0.03-2.17%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 7.80% | 4.75% | -20.77% | -22.29% | -39.98% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 7.80% | 4.75% | -20.77% | -22.29% | -39.98% |
| Cost of Revenue | 11.34% | 8.19% | 4.88% | 2.87% | -40.83% |
| Gross Profit | 0.66% | -2.19% | -98.89% | -98.91% | -38.19% |
| SG&A Expenses | -7.43% | -10.05% | 41.04% | 38.34% | -11.92% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 52.10% | 53.46% | 2,451.39% | 2,402.94% | -727.95% |
| Total Operating Expenses | 12.19% | 9.02% | 37.12% | 34.49% | -41.57% |
| Operating Income | -41.37% | -43.04% | -765.80% | -749.19% | -13.60% |
| Income Before Tax | -262.45% | -257.82% | -44.02% | -41.25% | 78.82% |
| Income Tax Expenses | -134.17% | -133.20% | -523.79% | -515.71% | 121.79% |
| Earnings from Continuing Operations | -31,550.00% | -31,225.00% | -11.24% | -9.10% | -100.08% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -92.17% | -92.42% | 1,145.60% | 1,121.63% | -39.22% |
| Net Income | -223.95% | -220.44% | -6.26% | -4.22% | -85.65% |
| EBIT | -41.37% | -43.04% | -765.80% | -749.19% | -13.60% |
| EBITDA | -10.77% | -13.30% | -1,167.41% | -1,531.07% | -9.67% |
| EPS Basic | -205.00% | -202.44% | -8.30% | -6.20% | -85.07% |
| Normalized Basic EPS | -149.21% | -148.44% | -410.00% | -398.99% | -- |
| EPS Diluted | -205.00% | -202.44% | -8.35% | -6.35% | -85.07% |
| Normalized Diluted EPS | -149.21% | -148.44% | -410.00% | -398.99% | -- |
| Average Basic Shares Outstanding | 18.91% | 18.91% | -1.87% | -1.87% | -4.22% |
| Average Diluted Shares Outstanding | 18.91% | 18.91% | -1.87% | -1.87% | -4.22% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |